Showing results (1-10 of 202) with videos related to
Sort By:
Pageof 21
Seminars in Immunology|May 11, 2021
Shocking HIV-1 with immunomodulatory latency reversing agentsAnna Kula-Pacurar, Anthony Rodari, Gilles Darcis, et al.Frontiers in Cellular and Infection Microbiology|May 30, 2023
Corrigendum: Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latencyAlexander O Pasternak, Olivier Rohr, Carine Van Lint, et al.Trends in Immunology|January 12, 2017
HIV Latency: Should We Shock or Lock?Gilles Darcis, Benoit Van Driessche, Carine Van LintMethods in Molecular Biology (Clifton, N.J.)|January 5, 2022
Jurkat-Derived (J-Lat, J1.1, and Jurkat E4) and CEM-Derived T Cell Lines (8E5 and ACH-2) as Models of Reversible Proviral LatencyAnthony Rodari, Guido Poli, Carine Van LintCurrent Opinion in HIV and AIDS|June 4, 2016
Preclinical shock strategies to reactivate latent HIV-1: an updateGilles Darcis, Benoît Van Driessche, Carine Van LintViruses|December 8, 2020
Depicting HIV-1 Transcriptional Mechanisms: A Summary of What We KnowAntoine Dutilleul, Anthony Rodari, Carine Van LintClinical Epigenetics|September 26, 2015
Epigenetic control of HIV-1 post integration latency: implications for therapyAmit Kumar, Gilles Darcis, Carine Van Lint, et al.Current Opinion in Virology|September 12, 2019
Applications of CRISPR/Cas9 tools in deciphering the mechanisms of HIV-1 persistenceRoxane Verdikt, Gilles Darcis, Amina Ait-Ammar, et al.Annual Review of Virology|September 29, 2021
The Current Status of Latency Reversing Agents for HIV-1 RemissionAnthony Rodari, Gilles Darcis, Carine M Van LintCurrent Topics in Microbiology and Immunology|October 27, 2017
Molecular Control of HIV and SIV LatencyGilles Darcis, Benoit Van Driessche, Sophie Bouchat, et al.Pageof 21